THOC5 Human Pre-designed siRNA Set A contains three designed siRNAs for THOC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THOC6 Human Pre-designed siRNA Set A contains three designed siRNAs for THOC6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THOC7 Human Pre-designed siRNA Set A contains three designed siRNAs for THOC7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THOP1 Human Pre-designed siRNA Set A contains three designed siRNAs for THOP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THPO Human Pre-designed siRNA Set A contains three designed siRNAs for THPO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THRA Human Pre-designed siRNA Set A contains three designed siRNAs for THRA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THRAP3 Human Pre-designed siRNA Set A contains three designed siRNAs for THRAP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THRB Human Pre-designed siRNA Set A contains three designed siRNAs for THRB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Thromboxane B2-D4 is the deuterium labeled Thromboxane B2. Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation[1][2].

Thromboxane B2-D4 is the deuterium labeled Thromboxane B2. Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation[1][2].

Thromboxane B3 is a prostaglandin analog derived from arachidonic acid (AA) in the cyclooxygenase (COX) metabolic pathway. Thromboxane B3 is generated from arachidonic acid (AA) in platelets and vascular endothelial cells through the catalysis of cyclooxygenase (COX) and thromboxane synthase (TXS). Thromboxane B3 has been reported to be formed by human platelets upon ingestion of […]

THRSP Human Pre-designed siRNA Set A contains three designed siRNAs for THRSP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THSD1 Human Pre-designed siRNA Set A contains three designed siRNAs for THSD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THSD4 Human Pre-designed siRNA Set A contains three designed siRNAs for THSD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THSD7A Human Pre-designed siRNA Set A contains three designed siRNAs for THSD7A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THSD7B Human Pre-designed siRNA Set A contains three designed siRNAs for THSD7B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THTPA Human Pre-designed siRNA Set A contains three designed siRNAs for THTPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THUMPD1 Human Pre-designed siRNA Set A contains three designed siRNAs for THUMPD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THUMPD2 Human Pre-designed siRNA Set A contains three designed siRNAs for THUMPD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THUMPD3 Human Pre-designed siRNA Set A contains three designed siRNAs for THUMPD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

THY1 Human Pre-designed siRNA Set A contains three designed siRNAs for THY1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Thymidine 5′-diphosphate (dTDP) sodium is the key product of pyrimidine synthesis in organisms. Thymidine 5′-diphosphate sodium is produced by thymidylate kinase (TMPK) catalyzed phosphorylation of 5′-thymidine monophosphate (dTMP), which requires ATP and Mg2+. Thymidine 5′-diphosphate sodium is further catalyzed by TMPK to thymidine 5′-triphosphate (dTTP). TMPK activity can be detected by measuring the level of […]

Thymidine-5′-monophosphate (disodium) salt (Standard) is the analytical standard of Thymidine-5′-monophosphate (disodium) salt. This product is intended for research and analytical applications. Thymidine-5′-monophosphate disodium salt is an endogenous metabolite.

Thymol Blue sodium is an acid-base indicator used to indicate changes in pH. Thymol Blue sodium fades from red to yellow at pH 1.2 to 2.8 and from yellow to blue at pH 8.0 to 9.6[1]. Storage: protect from light.

Thymol Blue sodium is an acid-base indicator used to indicate changes in pH. Thymol Blue sodium fades from red to yellow at pH 1.2 to 2.8 and from yellow to blue at pH 8.0 to 9.6[1]. Storage: protect from light.

Thymol Blue sodium is an acid-base indicator used to indicate changes in pH. Thymol Blue sodium fades from red to yellow at pH 1.2 to 2.8 and from yellow to blue at pH 8.0 to 9.6[1]. Storage: protect from light.

Thymolphthalein is an electrochemically active dye due to the presence of thymol fragments. Thymolphthalein is a Phthalein dye used as an acid-base indicator. It is colourless in acid pH and is blue in basic pH[1].

THYN1 Human Pre-designed siRNA Set A contains three designed siRNAs for THYN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Thyroid hormone receptor antagonist (1-850) is a competitive, selective and high-affinity thyroid hormone receptor (TR) antagonist with an IC50 of 1.5 μM for antagonizing the effect of T3 on TR. Thyroid hormone receptor antagonist (1-850) blocks T3-mediated interaction of TRα and TRβ with nuclear receptor coactivator. Thyroid hormone receptor antagonist (1-850) has no effect on […]

TIA1 Human Pre-designed siRNA Set A contains three designed siRNAs for TIA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tiagabine-d4 hydrochloride is deuterated labeled Tiagabine hydrochloride (HY-B0696A). Tiagabine hydrochloride is a potent and selective GABA reuptake inhibitor, used as an anticonvulsant agent, with IC50s of 67, 446 and 182 nM for [3H]GABA uptake in Synaptosomes, Neurons and Glia, respectively[1].

TIAL1 Human Pre-designed siRNA Set A contains three designed siRNAs for TIAL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIAM1 Human Pre-designed siRNA Set A contains three designed siRNAs for TIAM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIAM2 Human Pre-designed siRNA Set A contains three designed siRNAs for TIAM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tiaramide (RHC 2592-A) hydrochloride is an analgesic agent with antiallergic activity, and is also a non-steroidal, anti-inflammatory compound. Tiaramide hydrochloride inhibits histamine release[1].

TICAM1 Human Pre-designed siRNA Set A contains three designed siRNAs for TICAM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TICAM2 Human Pre-designed siRNA Set A contains three designed siRNAs for TICAM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TICRR Human Pre-designed siRNA Set A contains three designed siRNAs for TICRR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TID43 is a CK2 inhibitor, with an IC50 of 0.3 μM. TID43 can be used for anti-angiogenic research[1].

TIE1 Human Pre-designed siRNA Set A contains three designed siRNAs for TIE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.